Market Overview

Why Aptose Biosciences Stock Is Trading Lower Today


Aptose Biosciences (NASDAQ: APTO) shares are trading lower on continued momentum following the company's CG-806 presentation last Sunday at the 2020 American Society of Hematology Annual Meeting.

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

Aptose Biosciences shares were trading down 7.56% at $4.70 during the time of publication. The stock has a 52-week high of $9.25 and a 52-week low of $2.82.


Related Articles (APTO)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at